Visit our USA website
Alzheimer’s Medication
New Alzheimer's Medications Available
Is your loved one’s memory fading? Access two new Alzheimer’s treatments only available at our private UK clinics, approved by the MHRA. Whether you’re from the UK or not, you can benefit from innovative therapies designed to slow cognitive decline and improve quality of life.
As global leaders in Alzheimer’s research and clinical trials, we are more experienced than any other clinic in the UK in providing both of these new generation treatments for Alzheimer’s Disease.
Fill out our form or call us now and we’ll be in touch to see if we can help.
"*" indicates required fields
Making revolutionary changes in Alzheimer’s treatment
Getting access to these new medications has been eagerly awaited, especially as the tragic consequences of Alzheimer’s Disease affect so many. Alzheimer’s relentless progression takes away personal independence and quality of life, destroys the personality and the very essence of an individual, and creates enormous sadness for their family and friends.
Making a real change in any disease requires not only new revolutionary medications, but also the ability to detect the disease at the earliest possible moment – ideally, even before symptoms begin – to slow, stop, and eventually prevent the onset and progression of symptoms.
As the most experienced provider in the field, Re:Cognition Health can now prescribe medication for Alzheimer’s Disease privately, following MHRA approval.
What are the new Alzheimer’s medications?
Both drugs are monoclonal antibodies designed to target and clear amyloid-beta plaques in the brain, a hallmark of Alzheimer’s. By reducing these toxic proteins, they help slow cognitive decline and disease progression, offering hope for patients in the early stages of the condition.
Why patients are travelling to the UK for treatment
These groundbreaking treatments are not yet available in many European countries, and it remains uncertain when they will become widely accessible in the NHS.
Patients from across Europe and beyond are now travelling to our UK clinics to access these innovative therapies and expert care. If you or a loved one could benefit from early treatment, we encourage you to get in touch and find out how we can help.
Who is eligible for these new Alzheimer’s treatments?
Call us today to discuss if you or a loved one are suitable for the new Alzheimer’s treatments.
- Eligibility: Confirmation of elevated amyloid protein by Amyloid PET or CSF analysis is mandatory.
- Treatment: Bi-weekly intravenous infusion or monthly intravenous infusion with monitoring via MRI scans
- Required: A study program partner (family member or friend) for regular contact.
- Follow-Up: Recommended amyloid re-assessment at 12 months, then at 18 or 24 months.
Real experiences of our clinical trials
Dr Emer MacSweeney, CEO and Founder of Re:Cognition Health, explains the new medications now available for Alzheimer’s disease.
We also hear from two clinical trial participants, Mike and David, and a clinical trial partner, Cheryl, who share how joining a trial for these new treatments has helped them.
Alzheimer's: A Turning Point?
Re:Cognition Health featured, recently, in BBC One’s Panorama, “Alzheimer’s: A Turning Point?”. This follows the journey of volunteers participating in clinical trials, at several Re:Cognition Health’s UK centres testing new generation medications over the past few years. During this time our teams have gain unparalleled experience in managing, safely, individuals taking these medications and their potential side effects. For those in the UK, you can still watch this on BBC iPlayer, and see first hand how the medications have been demonstrated to slow progression of Alzheimer’s and its symptoms.
Another option – clinical trials
We understand that private treatment isn’t possible for everyone. That’s why we also offer access to a range of new Alzheimer’s medications through clinical trials at our six UK centres.
Clinical trials are an opportunity to receive cutting-edge treatments at no cost. To take part, you simply need to meet the eligibility criteria, which our experienced team will carefully assess with you.
In most trials, participants are randomly assigned to receive either the active medication or a placebo at first. However, later stages often allow all participants access to the active treatment. Participation is completely free, and our team will support you every step of the way.
Participation in a clinical trial is completely free.
Giving Hope Through Clinical Trials – David’s Story
David was diagnosed with Alzheimer’s in 2016 after experiencing problems with his memory. He shares his story about joining the Clarity clinical trial at Re:Cognition Health.
